Potent agonist and antagonist analogues of luliberin containing an azaglycine residue in position 10.
作者信息
Dutta A S, Furr B J, Giles M B, Valcaccia B, Walpole A L
出版信息
Biochem Biophys Res Commun. 1978 Mar 30;81(2):382-90. doi: 10.1016/0006-291x(78)91544-9.
PMID:352347
Abstract
摘要
相似文献
1
Potent agonist and antagonist analogues of luliberin containing an azaglycine residue in position 10.在第10位含有氮杂甘氨酸残基的促黄体素释放激素的强效激动剂和拮抗剂类似物。
Biochem Biophys Res Commun. 1978 Mar 30;81(2):382-90. doi: 10.1016/0006-291x(78)91544-9.
2
Synthesis and biological activity of highly active alpha-aza analogues of luliberin.促黄体素释放激素高活性α-氮杂类似物的合成与生物活性
J Med Chem. 1978 Oct;21(10):1018-24. doi: 10.1021/jm00208a004.
3
Induction of ovulation by luteinizing hormone-releasing hormone (LH-RH) and its analogues in rats under various preovulating sexual conditions.
Endocrinol Jpn. 1978 Oct;25(5):503-9. doi: 10.1507/endocrj1954.25.503.
4
Luteinizing hormone releasing hormone agonists induce ovulation in hypophysectomized proestrous rats: direct ovarian effect.
Life Sci. 1981 Jul 13;29(2):185-92. doi: 10.1016/0024-3205(81)90287-3.
5
Ovarian gonadotropin-releasing hormone receptors. II. Regulation and effects on ovarian development.卵巢促性腺激素释放激素受体。II. 调节及其对卵巢发育的影响。
Endocrinology. 1980 Aug;107(2):414-21. doi: 10.1210/endo-107-2-414.
6
Effects of high doses of a series of new luteinizing hormone-releasing hormone analogues in intact female rats.一系列高剂量新型促黄体生成激素释放激素类似物对未切除卵巢雌性大鼠的影响。
Br J Cancer. 1979 Mar;39(3):274-9. doi: 10.1038/bjc.1979.51.
7
[Effect of a cyclic luliberin analog on ovulation].[一种促黄体素释放素类似物对排卵的作用]
Probl Endokrinol (Mosk). 1985 Jul-Aug;31(4):52-5.
8
Inhibition of testicular luteinizing hormone receptor level by treatment with a potent luteinizing hormone-releasing hormone agonist of human chorionic gonadotropin.
Biochem Biophys Res Commun. 1977 Jun 6;76(3):855-62. doi: 10.1016/0006-291x(77)91579-0.
9
Oral contraceptive pretreatment in women undergoing controlled ovarian stimulation in ganirelix acetate cycles may, for a subset of patients, be associated with low serum luteinizing hormone levels, reduced ovarian response to gonadotropins, and early pregnancy loss.
Fertil Steril. 2009 May;91(5):1963-5. doi: 10.1016/j.fertnstert.2008.01.007. Epub 2008 Mar 12.
10
Effect of an LH-RH antagonist on reproductive status of immature female rats.促黄体生成素释放激素拮抗剂对未成熟雌性大鼠生殖状态的影响。
Experientia. 1978 Jun 15;34(6):813-4. doi: 10.1007/BF01947344.
引用本文的文献
1
Computational Investigation of Conformational Properties of Short Azapeptides: Insights from DFT Study and NBO Analysis.基于密度泛函理论（DFT）研究和自然键轨道（NBO）分析的短氮杂肽构象性质的计算研究。
Molecules. 2023 Jul 17;28(14):5454. doi: 10.3390/molecules28145454.
2
In Search of NPY YR Antagonists: Incorporation of Carbamoylated Arginine, Aza-Amino Acids, or d-Amino Acids into Oligopeptides Derived from the C-Termini of the Endogenous Agonists.寻找神经肽Y Y受体拮抗剂：将氨甲酰化精氨酸、氮杂氨基酸或D-氨基酸引入源自内源性激动剂C末端的寡肽中。
ACS Omega. 2017 Jul 31;2(7):3616-3631. doi: 10.1021/acsomega.7b00451. Epub 2017 Jul 14.
3
Goserelin: a review of its use in the treatment of early breast cancer in premenopausal and perimenopausal women.戈舍瑞林：用于治疗绝经前和围绝经期妇女早期乳腺癌的综述
Drugs. 2005;65(18):2639-55. doi: 10.2165/00003495-200565180-00011.
4
Gonadotrophin-releasing hormone agonists. A guide to use and selection.促性腺激素释放激素激动剂。使用与选择指南。
Drugs. 1994 Jul;48(1):41-58. doi: 10.2165/00003495-199448010-00005.
5
The development of tamoxifen for breast cancer therapy: a tribute to the late Arthur L. Walpole.他莫昔芬用于乳腺癌治疗的研发历程：缅怀已故的亚瑟·L·沃波尔
Breast Cancer Res Treat. 1988 Jul;11(3):197-209. doi: 10.1007/BF01807278.
6
The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.4-羟基雄烯二酮单独及联合戈舍瑞林对绝经前晚期乳腺癌女性的临床及内分泌影响。
Br J Cancer. 1990 Oct;62(4):679-83. doi: 10.1038/bjc.1990.356.
7
Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions.戈舍瑞林。对其药效学和药代动力学特性以及在性激素相关病症中的临床应用的综述。
Drugs. 1991 Feb;41(2):254-88. doi: 10.2165/00003495-199141020-00008.
8
Effects of high doses of a series of new luteinizing hormone-releasing hormone analogues in intact female rats.一系列高剂量新型促黄体生成激素释放激素类似物对未切除卵巢雌性大鼠的影响。
Br J Cancer. 1979 Mar;39(3):274-9. doi: 10.1038/bjc.1979.51.
9
Anti-tumour activity of ICI 118630, a new potent luteinizing hormone-releasing hormone agonist.新型强效促黄体生成素释放激素激动剂ICI 118630的抗肿瘤活性
Br J Cancer. 1979 Mar;39(3):268-73. doi: 10.1038/bjc.1979.50.
Zotero 插件